Cardiac Safety of High-dose Micafungin
- PMID: 29081623
- PMCID: PMC5642128
- DOI: 10.4103/jpp.JPP_37_17
Cardiac Safety of High-dose Micafungin
Conflict of interest statement
Both authors have received grant funding from Astellas US Pharma, Inc.
Figures
References
-
- Cleary JD, Stover KR. Antifungal-associated drug-induced cardiac disease. Clin Infect Dis. 2015;61(Suppl 6):S662–8. - PubMed
-
- Stover KR, Farley JM, Kyle PB, Cleary JD. Cardiac toxicity of some echinocandin antifungals. Expert Opin Drug Saf. 2014;13:5–14. - PubMed
-
- Stover KR, Cleary JD. Cardiac response to centrally administered echinocandin antifungals. J Pharm Pharmacol. 2015;67:1279–83. - PubMed
-
- Stover KR, King ST, Cleary JD. Cardiac toxicity of the echinocandins: Chance or cause and effect association? J Clin Pharm Ther. 2014;39:1–3. - PubMed
LinkOut - more resources
Full Text Sources
